MedPath
HSA Approval

VALPROATE-AFT Solution for Infusion/ Injection 100mg/ml

SIN16642P

VALPROATE-AFT Solution for Infusion/ Injection 100mg/ml

VALPROATE-AFT Solution for Infusion/ Injection 100mg/ml

November 16, 2022

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

N03AG01

valproic acid

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

LABIANA Pharmaceuticals

Active Ingredients

Sodium Valproate

100 mg/ml

Valproic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.